The movie "Field of Dreams" had a memorable line
Post# of 72440
"Build it and they will come".
Mgt is currently building a company that could/should become a blockbuster in biotech when Brilacidin and Kevetrin are fully developed. Is this a guaranteed success, no, but nothing is in biotech. But with all the indications that both drugs will be able to address, and more importantly address SAFELY, even a decent percentage of successful indications will make stockholders quite happy.
Mgt has been taking the steps necessary and advancing the program block by block, one small success after another. The licensing announced yesterday shows the company is now taking much larger steps and in the future, IMO, each succeeding step will be larger and larger.
The only thing mgt cannot control is the share price. Would be nice to see it skyrocket now, but bit by bit the building blocks forming the company with each successful advancement of the pipeline will become more and more important in advancing the share price. Soon we may see some building blocks advance the share price quite nicely.
So focus on what mgt can do, what they are doing, and the successful steps they are bringing to fruition to advance the company.
Focusing on the share price on a daily basis is the mark of a fool and not an investor since the share price can still be easily manipulated.
In "Field of Dreams", the world didn't really NEED a ball field, they just wanted one. In the real world, tens if not hundreds of thousands of people NEED IPIX drugs and the curative abilities they will bring to many areas of medicine.
Thanks to mgt for working so hard in building investors "Field of Dreams".